CEL Sci Corp: Form 10-Q for the period ended Jun 30, 2013
Filed with the SEC on Aug 9, 2013 and accepted by EDGAR at Aug 9, 2013, 20:30 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2013-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Research and development | 3 months2013-04-01 to 2013-06-30 | $3.8m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2012-10-01 to 2013-06-30 | $9.2m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2013-04-01 to 2013-06-30 | −$5.5m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2012-10-01 to 2013-06-30 | −$14.8m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2013-04-01 to 2013-06-30 | $42.7k | us-gaap:InterestExpense |
| Interest expense | 9 months2012-10-01 to 2013-06-30 | $127.8k | us-gaap:InterestExpense |
| Net income | 3 months2013-04-01 to 2013-06-30 | −$4.4m | us-gaap:NetIncomeLoss |
| Net income | 9 months2012-10-01 to 2013-06-30 | −$7.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2013-04-01 to 2013-06-30 | −$0.02 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2012-10-01 to 2013-06-30 | −$0.05 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2013-04-01 to 2013-06-30 | −$0.01 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2012-10-01 to 2013-06-30 | −$0.03 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2013-04-01 to 2013-06-30 | 309,306,502 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2012-10-01 to 2013-06-30 | 300,383,239 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2012-10-01 to 2013-06-30 | −$10.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2012-10-01 to 2013-06-30 | $93.4k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2013-06-30 | $3.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2013-06-30 | $6.2m | us-gaap:AssetsCurrent |
| Total assets | At period end2013-06-30 | $14.8m | us-gaap:Assets |
| Current liabilities | At period end2013-06-30 | $3.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2013-06-30 | $7.0m | us-gaap:Liabilities |
| Shareholders' equity | At period end2013-06-30 | $7.8m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001354488-13-004317. Last ingested by Listed: Oct 24, 2026, 14:55 ET. Listed shows no prices and gives no investment advice.